Yale Jen
Stock Analyst at Laidlaw & Co.
(0.22)
# 4,486
Out of 5,182 analysts
16
Total ratings
12.5%
Success rate
-18.08%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KZIA Kazia Therapeutics | Initiates: Buy | $25 | $11.85 | +110.97% | 1 | Apr 15, 2026 | |
| PTN Palatin Technologies | Initiates: Buy | $60 | $21.21 | +182.95% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.37 | +1,642.63% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $2.91 | +656.01% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences Holdings | Initiates: Buy | $5 | $0.96 | +423.40% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $52.76 | +99.01% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $8.69 | +118.64% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $120 | $7.10 | +1,590.16% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $109.87 | -56.31% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $0.86 | +55,132.56% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $225 | $1.53 | +14,605.88% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.68 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.44 | +2,153.27% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.59 | - | 1 | Aug 15, 2023 |
Kazia Therapeutics
Apr 15, 2026
Initiates: Buy
Price Target: $25
Current: $11.85
Upside: +110.97%
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $21.21
Upside: +182.95%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.37
Upside: +1,642.63%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $2.91
Upside: +656.01%
Senti Biosciences Holdings
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $0.96
Upside: +423.40%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $52.76
Upside: +99.01%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $8.69
Upside: +118.64%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $120
Current: $7.10
Upside: +1,590.16%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $109.87
Upside: -56.31%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $0.86
Upside: +55,132.56%
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $1.53
Upside: +14,605.88%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.68
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.44
Upside: +2,153.27%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.59
Upside: -